Fagerhult Group AB header image

Fagerhult Group AB

FAG

Equity

ISIN SE0010048884 / Valor 37094121

NASDAQ Nordic Exchange Stockholm, Equities (2025-11-17)
SEK 42.15+0.96%

Fagerhult Group AB
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Fagerhult Group AB is a Swedish company specializing in the development and production of professional lighting solutions. With a focus on Human Centric Lighting, the company aims to create lighting systems that enhance both physical and mental well-being. Fagerhult leverages scientific research to design products that cater to the needs of various environments, including offices, educational institutions, healthcare facilities, and retail spaces. The company's approach integrates advanced technology and design to improve the quality of light, thereby influencing the comfort and productivity of individuals in illuminated spaces. As a prominent player in the lighting industry, Fagerhult continues to innovate and expand its product offerings to meet the evolving demands of its global clientele.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (18.10.2025):

Fagerhult Group AB has released its financial results for the second quarter of January–June 2025, showing a decline in both order intake and net sales compared to the previous year. The decrease was largely due to an IT incident at the Whitecroft business in the UK. Despite these challenges, the company improved its operating cash flow and continued to pursue strategic acquisitions and innovations to support future growth.

Order Intake Decline

Order intake for Q2 was 1,905 MSEK, representing a -6.5% organic decline compared to the previous year. High volatility in remaining businesses and significant currency effects of -88 MSEK contributed to the overall decrease.

Net Sales Reduction

Net sales for the quarter were 1,848 MSEK, a -14.7% decrease adjusted to -10.4% after accounting for currency effects. The IT incident at Whitecroft in May led to a reduction of 21 MSEK in net sales.

Operating Profit and Margins

Operating profit before IAC was 119.3 MSEK, a -39.3% decrease from the previous year. The operating margin before IAC dropped to 6.5% from 9.1%, despite an increase in gross profit margins.

Strategic Acquisitions and Innovation

Fagerhult completed the acquisition of Trato TLV Group and announced the acquisition of Capelon to enhance its smart lighting offerings. The company is focusing on cost reductions and innovation to improve order intake and drive long-term growth.

Summarized from source with an LLMView Source

Key figures

-29.8%1Y
-7.77%3Y
-4.20%5Y

Performance

31.5%1Y
35.2%3Y
35.6%5Y

Volatility

Market cap

783 M

Market cap (USD)

Daily traded volume (Shares)

44,392

Daily traded volume (Shares)

1 day high/low

54.6 / 53.8

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Pegasystems Inc
Pegasystems Inc Pegasystems Inc Valor: 503997
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.87%USD 54.65
Blueprint Medicines Corp
Blueprint Medicines Corp Blueprint Medicines Corp Valor: 27670715
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 129.46
Halozyme Therapeutics Inc
Halozyme Therapeutics Inc Halozyme Therapeutics Inc Valor: 1814799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.76%USD 70.56
Nutanix Inc
Nutanix Inc Nutanix Inc Valor: 30912711
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.99%USD 64.60
Tarsus Pharmaceuticals Inc
Tarsus Pharmaceuticals Inc Tarsus Pharmaceuticals Inc Valor: 57410241
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.71%USD 74.17
Flywire Corp
Flywire Corp Flywire Corp Valor: 111444572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.51%USD 13.57
Sezzle Inc
Sezzle Inc Sezzle Inc Valor: 129105133
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%USD 50.97
PAR Technology Corporation
PAR Technology Corporation PAR Technology Corporation Valor: 960461
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.66%USD 36.70
Toast Inc
Toast Inc Toast Inc Valor: 113470913
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.31%USD 34.71
Sportradar Group AG
Sportradar Group AG Sportradar Group AG Valor: 113423966
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.33%USD 21.81